Results 51 to 60 of about 1,296 (182)
, 1986 The effects of amrinone, dobutamine, and a combination of the two drugs on peak positive left ventricular dP/dt and left ventricular performance were evaluated in 11 patients with chronic congestive heart failure. When administered alone, both dobutamine
D Lucido, H Rutman, J Gage, T H LeJemtel
core +1 more source
Кубанский научный медицинский вестник, 2016 The efficacy of cardiotonic drugs on the energy supply system and bioenergetic processes in failing myocardium under severe form heart failure (HF) coupled with systemic inflammatory response syndrom, has been studied in the randomized, controlled trial.
D. I. Ionov +6 more
doaj
Positive hemodynamic interaction between amrinone and diltiazem in anesthetized dogs
, 1989 The direct negative inotropic actions of calcium channel blockers limit the use of these otherwise effective systemic and coronary vasodilators in patients with heart failure.
E. Dagher, C. Chartrand, L. Dumont
core +1 more source
Effects of amrinone, a cardiotonic drug, on calcium movements in dog erythrocytes. [PDF]
, 1980 Dog erythrocytes (RBC) have a system for passive Ca and Na movements that resembles the Ca-Na exchanger first described in cardiac muscle. Amrinone, a new cardiotonic drug active in humans with congestive heart failure, is shown to stimulate net Ca ...
J R Harper +3 more
core +1 more source
On the conformational structure of amrinone and milrinone
, 1987 Based on the ab initio STO-3G method including geometry optimization, a conformational analysis of the bipyridine cardiotonics amrinone and milrinone was performed. The results indicate a considerably twisted structure for both molecules.
CIMIRAGLIA, Renzo, H. Hofmann
core +1 more source
The role of amrinone in potential heart transplant patients with pulmonary hypertension [PDF]
, 1989 Orthotopic heart transplantation is contraindicated in patients with pulmonary hypertension and an elevated pulmonary vascular resistance. In an attempt to make otherwise unacceptable patients possible candidates for heart transplantation, amrinone was ...
Deeb, G. Michael, Boiling, Steven F.
core +1 more source
Clinical applications of amrinone
Journal of Cardiothoracic Anesthesia, 1989 A bipyridine derivative, amrinone is a noncatecholamine, nonglycoside alternative in the treatment of perioperative myocardial dysfunction. A type-3 phosphodiesterase enzyme inhibitor, amrinone combines positive inotropic support with systemic and pulmonary vasodilation.
openaire +2 more sources
, 1996 BACKGROUND: Amrinone is a noncatecholamine, nonglycoside agent with both inotropic and vasodilatory properties and therefore seems suitable for therapy of right ventricular(RV) dysfunction.
곽영란
core +1 more source
Effects of amrinone, a phosphodiesterase inhibitor, on right ventricular/arterial coupling immediately after cardiac operations [PDF]
, 1998 Objective: Amrinone, a selective phosphodiesterase III inhibitor, is reported to have a potent inotropic effect on the left ventricle, but the effects of this drug on right ventricular contractility in the clinical setting are unknown.
Yasui, Hisataka +5 more
core +1 more source
Oral amrinone in refractory congestive heart failure.
, 1980 The acute effects of an oral preparation of amrinone, a recently synthesized cardiotonic agent, were assessed noninvasively in nine patients who had advanced heart failure that persisted despite treatment with digitalis, diuretic drugs and afterload ...
Smith, T W +7 more
core +1 more source